Chinami Makii

Shinjuku, 1690073, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Prevalence and metronidazole resistance of Trichomonas vaginalis among Japanese women in 2021.

Prevalence and metronidazole resistance of Trichomonas vaginalis among Japanese women in 2021.

Journal: IJID regions
Published: January 26, 2023

Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.

Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.

Journal: Cancer science
Published: April 22, 2020

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.

Journal: Gynecologic oncology
Published: May 07, 2019

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

Journal: Oncotarget
Published: May 14, 2016

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.

Journal: Gynecologic oncology
Published: February 02, 2016

Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.

Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.

Journal: Oncotarget
Published: November 15, 2015

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.

Journal: Oncology letters
Published: July 25, 2015

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

Journal: PloS one
Published: July 07, 2015

Putative tumor suppression function of SIRT6 in endometrial cancer.

Putative tumor suppression function of SIRT6 in endometrial cancer.

Journal: FEBS letters
Published: March 16, 2015

PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

Journal: Gynecologic oncology
Published: December 29, 2014

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.

Journal: PloS one
Published: September 03, 2014

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

Journal: PloS one
Published: September 30, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026